| Trial ID: | L0022 |
| Source ID: | NCT01712711
|
| Associated Drug: |
H.pylori eradication
|
| Title: |
Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT01712711/results
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: H.pylori eradication
|
| Outcome Measures: |
Liver Fat Content Change From Baseline to Six Weeks Post H.Pylori Treatment
|
| Sponsor/Collaborators: |
Tehran University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 Years to 45 Years ?? (Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
40
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
September 2012
|
| Completion Date: |
March 2013
|
| Results First Posted: |
May 6, 2013
|
| Last Update Posted: |
June 28, 2018
|
| Locations: |
Gastroenterology clinic, Sina Hospital, Tehran, Iran, Islamic Republic of
|
| URL: |
https://ClinicalTrials.gov/show/NCT01712711
|
